Published in J Infect Dis on February 01, 1999
Ebola Virus Disease Survivors: Clinical and Immunologic Follow-up | NCT02431923
Persistence of Ebola Virus in Ocular Fluid during Convalescence. N Engl J Med (2015) 5.92
Clinical manifestations and case management of Ebola haemorrhagic fever caused by a newly identified virus strain, Bundibugyo, Uganda, 2007-2008. PLoS One (2012) 2.33
Early clinical sequelae of Ebola virus disease in Sierra Leone: a cross-sectional study. Lancet Infect Dis (2015) 1.94
Outbreaks of Ebola virus disease in Africa: the beginnings of a tragic saga. J Venom Anim Toxins Incl Trop Dis (2014) 1.72
Uveitis and Systemic Inflammatory Markers in Convalescent Phase of Ebola Virus Disease. Emerg Infect Dis (2016) 1.62
Ebola and Marburg hemorrhagic fevers: neglected tropical diseases? PLoS Negl Trop Dis (2012) 1.51
Viral infections during pregnancy. Am J Reprod Immunol (2015) 1.17
Gastrointestinal and Hepatic Manifestations of Ebola Virus Infection. Dig Dis Sci (2015) 1.06
Ebola Virus Disease Complications as Experienced by Survivors in Sierra Leone. Clin Infect Dis (2016) 0.99
Post-Ebola Syndrome, Sierra Leone. Emerg Infect Dis (2016) 0.97
The cost of an Ebola case. Pathog Glob Health (2015) 0.84
What we know about ocular manifestations of Ebola. Clin Ophthalmol (2014) 0.82
A new era of uveitis: impact of polymerase chain reaction in intraocular inflammatory diseases. Jpn J Ophthalmol (2016) 0.81
Neurological Complications of Ebola Virus Infection. Neurotherapeutics (2016) 0.81
Ebola Virus Disease, Democratic Republic of the Congo, 2014. Emerg Infect Dis (2016) 0.81
Necrotizing Scleritis, Conjunctivitis, and Other Pathologic Findings in the Left Eye and Brain of an Ebola Virus-Infected Rhesus Macaque (Macaca mulatta) With Apparent Recovery and a Delayed Time of Death. J Infect Dis (2015) 0.80
Strengthening Health Systems While Responding to a Health Crisis: Lessons Learned by a Nongovernmental Organization During the Ebola Virus Disease Epidemic in Sierra Leone. J Infect Dis (2016) 0.79
[Tropical ophthalmology : Intraocular inflammation caused by "new" infectious pathogens and travel-related infections]. Ophthalmologe (2016) 0.78
Neglected filoviruses. FEMS Microbiol Rev (2016) 0.78
Ophthalmic Manifestations and Causes of Vision Impairment in Ebola Virus Disease Survivors in Monrovia, Liberia. Ophthalmology (2016) 0.78
Novel Retinal Lesion in Ebola Survivors, Sierra Leone, 2016. Emerg Infect Dis (2017) 0.77
Ocular Manifestations of Ebola Virus Disease: An Ophthalmologist's Guide to Prevent Infection and Panic. Biomed Res Int (2015) 0.76
Updates in diagnosis and management of Ebola hemorrhagic fever. J Res Med Sci (2016) 0.75
Preparing for Serious Communicable Diseases in the United States: What the Ebola Virus Epidemic Has Taught Us. Microbiol Spectr (2016) 0.75
Emerging causes of viral-associated uveitis. Int Ophthalmol Clin (2015) 0.75
Ocular problem in Ebola virus infection: A short review. Saudi J Ophthalmol (2015) 0.75
Ebola virus infection induces autoimmunity against dsDNA and HSP60. Sci Rep (2017) 0.75
Reflections on the Ebola Public Health Emergency of International Concern, Part 1: Post-Ebola Syndrome: The Silent Outbreak. J Glob Infect Dis (2017) 0.75
The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidémies à Kikwit. J Infect Dis (1999) 7.39
Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: clinical observations in 103 patients. J Infect Dis (1999) 5.59
Persistence and genetic stability of Ebola virus during the outbreak in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis (1999) 4.28
Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. International Scientific and Technical Committee. J Infect Dis (1999) 4.18
Use of specialised isolation media for recognition and identification of Candida dubliniensis isolates from HIV-infected patients. Eur J Clin Microbiol Infect Dis (1997) 3.86
Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe. EuroSIDA study group. AIDS (1999) 3.67
Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epidémies à Kikwit. J Infect Dis (1999) 3.36
Epidemic resurgence of Chikungunya virus in democratic Republic of the Congo: identification of a new central African strain. J Med Virol (2004) 2.94
Epidemiologic and clinical aspects of the Ebola virus epidemic in Mosango, Democratic Republic of the Congo, 1995. J Infect Dis (1999) 2.70
Rolling out antiretrovirals in Africa: there are still challenges ahead. Clin Infect Dis (2005) 2.43
HIV testing in developing countries. Lancet (1997) 2.19
A novel immunohistochemical assay for the detection of Ebola virus in skin: implications for diagnosis, spread, and surveillance of Ebola hemorrhagic fever. Commission de Lutte contre les Epidémies à Kikwit. J Infect Dis (1999) 1.96
Organization of patient care during the Ebola hemorrhagic fever epidemic in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis (1999) 1.86
Recurrence of blackwater fever: triggering of relapses by different antimalarials. Trop Med Int Health (1998) 1.75
Ebola outbreak in Kikwit, Democratic Republic of the Congo: discovery and control measures. J Infect Dis (1999) 1.73
Improvement of the patient flow in a large urban clinic with high HIV seroprevalence in Kampala, Uganda. Int J STD AIDS (2009) 1.59
Survey among survivors of the 1995 Ebola epidemic in Kikwit, Democratic Republic of Congo: their feelings and experiences. Trop Med Int Health (1998) 1.44
Ebola hemorrhagic fever and pregnancy. J Infect Dis (1999) 1.41
Ebola hemorrhagic fever: lessons from Kikwit, Democratic Republic of the Congo. J Infect Dis (1999) 1.41
Euthanasia: from the perspective of HIV infected persons in Europe. HIV Med (2001) 1.40
Isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection. Lancet (1998) 1.39
Efficacy of octreotide in the management of chronic diarrhoea in AIDS. AIDS (1992) 1.39
Rhodococcus equi infection in 3 AIDS patients. Acta Clin Belg (1996) 1.38
Primary care involvement in human immune deficiency virus infection-a pan-European view. The Eurosupport Study Group. Fam Pract (2000) 1.37
Sexual dysfunction associated with protease inhibitor containing highly active antiretroviral treatment. AIDS (2001) 1.35
Tuberculosis knowledge, attitudes and health-seeking behaviour in rural Uganda. Int J Tuberc Lung Dis (2011) 1.35
Identification and characterization of sera from HIV-infected individuals with broad cross-neutralizing activity against group M (env clade A-H) and group O primary HIV-1 isolates. J Med Virol (2000) 1.31
[Epidemic of Chikungunya virus in 1999 and 200 in the Democratic Republic of the Congo]. Med Trop (Mars) (2003) 1.28
Lactating mothers infected with Ebola virus: EBOV RT-PCR of blood only may be insufficient. Euro Surveill (2015) 1.28
Evaluation of a clinical case-definition of acquired immunodeficiency syndrome in Africa. Lancet (1987) 1.27
Sexual dysfunction in HIV-positive men is multi-factorial: a study of prevalence and associated factors. AIDS Care (2007) 1.25
Prevalence and factors associated with sexual dysfunction among HIV-positive women in Europe. AIDS Care (2004) 1.19
Response to antiretroviral therapy among patients exposed to three classes of antiretrovirals: results from the EuroSIDA study. Antivir Ther (2002) 1.19
Initiating antiretroviral treatment in a resource-constrained setting: does clinical staging effectively identify patients in need? Int J STD AIDS (2009) 1.18
Quality of life in asymptomatic- and symptomatic HIV infected patients in a trial of ritonavir/saquinavir therapy. The Prometheus Study Group. AIDS (2000) 1.18
Persistent diarrhea, strongly associated with HIV infection in Kinshasa, Zaire. Am J Gastroenterol (1987) 1.17
T cell activation, apoptosis and cytokine dysregulation in the (co)pathogenesis of HIV and pulmonary tuberculosis (TB). Clin Exp Immunol (2000) 1.17
Subset markers of CD8(+) cells and their relation to enhanced cytotoxic T-cell activity during human immunodeficiency virus infection. J Clin Immunol (1991) 1.15
Ebola between outbreaks: intensified Ebola hemorrhagic fever surveillance in the Democratic Republic of the Congo, 1981-1985. J Infect Dis (1999) 1.14
Male partner voluntary counselling and testing associated with the antenatal services in Kinshasa, Democratic Republic of Congo: a randomized controlled trial. Int J STD AIDS (2011) 1.10
Reply to Gonzalez and Everall: Lest we forget: neuropsychiatry and the new generation anti-HIV drugs. AIDS (1999) 1.08
Sexual dysfunction with protease inhibitors. Lancet (1999) 1.07
Families affected by HIV: parents' and children's characteristics and disclosure to the children. AIDS Care (2004) 1.06
Isolation of Candida species on media with and without added fluconazole reveals high variability in relative growth susceptibility phenotypes. Antimicrob Agents Chemother (1997) 1.06
Decreased CD40 ligand induction in CD4 T cells and dysregulated IL-12 production during HIV infection. Clin Exp Immunol (1999) 1.05
Treatment and prevention of multidrug-resistant tuberculosis. Drugs (1999) 1.05
Altered receptor expression and decreased sensitivity of T-cells to the stimulatory cytokines IL-2, IL-7 and IL-12 in HIV infection. Immunol Lett (1998) 1.04
Hospital based clinical surveillance for dengue haemorrhagic fever in Bandung, Indonesia 1994-1995. Acta Trop (2001) 1.04
Evaluation of the WHO clinical case definition for AIDS in rural Zaire. AIDS (1988) 1.04
Uptake of provider-initiated counselling and testing among tuberculosis suspects, Ethiopia. Int J Tuberc Lung Dis (2010) 1.01
Tuberculosis in human immunodeficiency virus infected Ugandan children starting on antiretroviral therapy. Int J Tuberc Lung Dis (2011) 1.01
Tuberculosis and human immunodeficiency virus co-infections and their predictors at a hospital-based HIV/AIDS clinic in Uganda. Int J Tuberc Lung Dis (2010) 1.00
Low frequency of liver enzyme elevation in HIV-infected patients attending a large urban treatment centre in Uganda. Int J STD AIDS (2010) 1.00
Clinical manifestations of dengue haemorrhagic fever in children in Bandung, Indonesia. Ann Soc Belg Med Trop (1995) 1.00
Portal vein thrombosis in a patient with HIV treated with a protease inhibitor-containing regimen. Acta Clin Belg (2006) 0.99
The immune reconstitution inflammatory syndrome related to HIV co-infections: a review. Eur J Clin Microbiol Infect Dis (2011) 0.99
Breastfeeding and transmission of HIV. Lancet (1989) 0.95
Superantigen activation of CD4+ and CD8+T cells from HIV-infected subjects: role of costimulatory molecules and antigen-presenting cells (APC) Clin Exp Immunol (1998) 0.95
Cassava food toxins, konzo disease, and neurodegeneration in sub-Sahara Africans. Neurology (2013) 0.94
CD8+ cells and not CD4+ T cells are hyporesponsive to CD28- and CD40L-mediated activation in HIV-infected subjects. Clin Exp Immunol (1997) 0.94
Serologic survey among hospital and health center workers during the Ebola hemorrhagic fever outbreak in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis (1999) 0.93
Determinants of generalized herpes simplex virus-2 epidemics: the role of sexual partner concurrency. Int J STD AIDS (2013) 0.93
Low prevalence of vitamin D deficiency in Ugandan HIV-infected patients with and without tuberculosis. Int J Tuberc Lung Dis (2012) 0.92
Comparison of sensitivities and specificities of latex agglutination and an enzyme-linked immunosorbent assay for detection of antibodies to the human immunodeficiency virus in African sera. J Clin Microbiol (1988) 0.92
Tuberculin skin test conversion among HIV patients on antiretroviral therapy in Uganda. Int J Tuberc Lung Dis (2013) 0.92
Natural residues versus antiretroviral drug-selected mutations in HIV type 1 group O reverse transcriptase and protease related to virological drug failure in vivo. AIDS Res Hum Retroviruses (2000) 0.92
Adult Still's disease caused by Yersinia enterocolitica infection. Arch Intern Med (1984) 0.92
A frontal mucocele caused by an immune reconstitution inflammatory syndrome in a patient with HIV infection. Rhinology (2008) 0.91
Evidence for circulating activated cytotoxic T cells in HIV-infected subjects before the onset of opportunistic infections. Clin Exp Immunol (1990) 0.90
Virologic, immunologic, and clinical follow-up of a couple infected by the human immunodeficiency virus type one, group O. J Med Virol (1997) 0.89
Immune reconstitution inflammatory syndrome in an HIV/TB co-infected patient four years after starting antiretroviral therapy. Acta Clin Belg (2007) 0.89
Surveillance case definition for AIDS in resource-poor countries. Lancet (1993) 0.89
Long-term disease surveillance in Bandundu region, Democratic Republic of the Congo: a model for early detection and prevention of Ebola hemorrhagic fever. J Infect Dis (1999) 0.89
Multiple tuberculous brain abscesses in an HIV-infected patient successfully treated with HAART and antituberculous treatment. Infection (2003) 0.89
Birds of a feather: homophily and sexual network structure in sub-Saharan Africa. Int J STD AIDS (2013) 0.88
Diagnosis of amoebic infection of the liver: report of 36 cases. Ann Soc Belg Med Trop (1995) 0.88
AIDS: an old disease from Africa? Br Med J (Clin Res Ed) (1984) 0.88
Clinical manifestations and the natural history of HIV infection in adults. West J Med (1987) 0.88
[Validity of an ELISA test for CD4+ T lymphocyte count and validity of total lymphocyte count in the assessment of immunodeficiency status in HIV infection]. Ann Soc Belg Med Trop (1994) 0.88
Deafness caused by didanosine. Eur J Clin Microbiol Infect Dis (1998) 0.87
Incidence and risk factors associated with lost to follow-up in a Belgian cohort of HIV-infected patients treated with highly active antiretroviral therapy. Int J STD AIDS (2010) 0.87
[Prevalence and incidence of HIV-1 infection among employees of a large textile business and their wives in Kinshasa, 1991-1996]. Rev Epidemiol Sante Publique (2001) 0.87
The role of non-viral load surrogate markers in HIV-positive patient monitoring during antiviral treatment. Int J STD AIDS (2004) 0.87